Investigating how a specific microRNA affects brain signaling and metabolism

Metabolic miR-137 Effects Contribute to Neuronal Signaling

['FUNDING_R21'] · COLORADO STATE UNIVERSITY · NIH-11072381

This study is looking at a tiny molecule in the brain called miR-137 to see how it affects brain signaling and metabolism, especially in people with Schizophrenia and Bipolar Disorder, and it hopes to find new ways to improve treatments for these conditions by understanding how brain health and metabolism are connected.

Quick facts

Phase['FUNDING_R21']
Study typeNih_funding
SexAll
SponsorCOLORADO STATE UNIVERSITY (nih funded)
Locations1 site (FORT COLLINS, UNITED STATES)
Trial IDNIH-11072381 on ClinicalTrials.gov

What this research studies

This research focuses on the role of microRNA miR-137, which is found in high levels in the brain and is linked to conditions like Schizophrenia and Bipolar Disorder. The study aims to understand how miR-137 influences both neuronal signaling and metabolic processes, particularly in relation to obesity and Type II Diabetes. Using a model organism called Drosophila, researchers will explore the connections between metabolic dysfunction and neuropsychiatric symptoms, with the goal of uncovering mechanisms that could lead to better treatments. Patients with these conditions may benefit from insights gained about the interplay between metabolism and brain health.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with Schizophrenia or Bipolar Disorder, particularly those experiencing metabolic complications.

Not a fit: Patients without neuropsychiatric disorders or significant metabolic issues may not receive direct benefits from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and treatment options for patients with neuropsychiatric disorders and metabolic issues.

How similar studies have performed: Previous research has shown promising results in understanding the role of microRNAs in metabolic and neuronal functions, suggesting potential for success in this area.

Where this research is happening

FORT COLLINS, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Conditions: adult onset diabetes, Adult-Onset Diabetes Mellitus, bipolar affective disorder, bipolar disease, Bipolar Disorder

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.